Condensed Interim Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from Operating Activities
Net Loss	$ (4,538,527)	$ (3,171,182)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Stock based compensation	400,450	676,341
Bad debt expense (recovery)	55,226	(70,004)
Change in fair market value of warrant liability	(11,717)	300,452
Gain on settlement of loan payable		(20,000)
Loss on change in fair market value of contingent consideration (Note 2)	240,000
Gain on settlement of contingent consideration	(1,700,000)
Loss on impairment of goodwill	1,138,203
Amortization of right-of-use asset	462,832
Depreciation and amortization	978,495	312,319
Amortization of debt discount	53,646
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	(402,965)	151,574
Cost and estimated earnings excess of billings	(262,420)
Inventory	(2,855,073)	(224,721)
Vendor deposits	494,888	(1,148,564)
Prepaid expenses and other current assets	(62,600)	201,537
Income taxes payable		(173,716)
Accounts payable and accrued expenses	768,872	(644,665)
Billings in excess of costs and earnings on uncompleted contracts	(616,475)
Deferred revenue	687,494	412,086
Due to landlord	(93,172)
Operating lease payments	(449,388)
Total Adjustments	(1,173,704)	(227,361)
Net Cash Used in Operating Activities	(5,712,231)	(3,398,543)
Cash Flows From Investing Activities
Cash paid for patent costs	(682)	(14,435)
Purchase of machinery and equipment	(26,043)
Acquisitions, net of cash acquired (Note 2)	(10)	(760,293)
Note receivable, related party		(500,000)
Net Cash Used in Investing Activities	(26,735)	(1,274,728)
Cash Flows From Financing Activities
Payments on financing leases	(3,493)	(3,258)
Proceeds from warrant exercise		1,157
Shares repurchased	(149,686)
Dividends to preferred shareholders	(724,500)
Settlement of loan payable		(65,000)
Proceeds from equity raises, net	1,092,000
Net Cash Provided by (Used in) Financing Activities	214,321	(67,101)
Net Decrease in Cash and equivalents	(5,524,645)	(4,740,372)
Cash, restricted cash, and cash equivalents beginning	8,768,156	11,757,930
Cash, restricted cash, and cash equivalents ending	3,243,511	7,017,558
Cash paid during the year for:
Interest	4,102	1,022
Income taxes		185,105
Supplemental Non-Cash Items
Initial recognition of warrant liability		135,125
Reclassification from liability to be settled in stock to additional paid in capital		21,420
Recognition of right of use asset-operating lease	$ 1,380,658